Correlation Engine 2.0
Clear Search sequence regions

The mineralocorticoid aldosterone is a key regulator of blood pressure, fluid and electrolyte homeostasis, and acts via the mineralocorticoid receptor (MR). In recent years, an increasing number of studies revealed deleterious effects of aldosterone via its receptor. Especially in patients with primary hyperaldosteronism (PHA) a significant higher risk of developing cardiovascular comorbidities and comortalities was reported. Also renal insufficiency is clearly increased in patients with PHA indicating a role of aldosterone and the MR in the pathogenesis of renal injury. It has been shown that aldosterone in combination with an elevated salt intake, leads to renal inflammation, fibrosis, podocyte injury, and mesangial cell proliferation. This review focuses on the current knowledge of aldosterone effects in the kidney and highlights this topic from 2 perspectives: from clinical medicine and from experimental studies. © Georg Thieme Verlag KG Stuttgart · New York.


V G Fourkiotis, G Hanslik, F Hanusch, J Lepenies, M Quinkler. Aldosterone and the kidney. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme. 2012 Mar;44(3):194-201

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 22161301

View Full Text